Profil bibliographique

Montserrat Arumí

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

34Publications signalées

155Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Ferroptosis and cancer prognosisGlioma Diagnosis and TreatmentRNA modifications and cancerCancer Immunotherapy and BiomarkersCancer Cells and Metastasis

Publications récentes

2026 conference-abstractOpenAlex

Abstract PS5-01-01: Concordance of genomic alterations between paired tissue (T) and plasma (P) samples analyzed with next generation sequencing (NGS) panels from patients (pts) with HER2-positive metastatic breast cancer (mBC)

Santiago Escrivá-de-Romaní, L. Ollé-Monràs, L. Joval-Ramentol, E. Álvarez Colomé et autres

0 citationsClinical Cancer Research

Accès ouvert 2025 preprintOpenAlex

Implementation of NGS Analysis for the Detection of RET Rearrangements in Thyroid Cancer Patients. An Inter-Laboratory Validation of the Method

Marta Sesé, Sergi Clavé, Rosa Somoza, Carles Zafón et autres

0 citationsPreprints.org

Accès ouvert 2023 articleOpenAlex

Usefulness of the baseline risk assessment guidelines to predict cancer therapy-related cardiac dysfunction in early-stage HER2 positive breast cancer

G Oristrell Santamaria, Sofía Vila‐Sanjuán, R. Vila, Río Aguilar et autres

0 citationsEuropean Heart Journal

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data files S1 a_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table S3 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table S1 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig. S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig. S3 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Table S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig S1 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Fig. S4 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina, Estela Pineda et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.